SCHEMBL19683548

SCHEMBL19683548

COC(COc1cc2c(OCC(OC)OC)cccc2cc1-c1ccccc1)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 6/20 0.40
CYP1A2 P05177 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA2A P29274 2/20 0.40
ADORA1 P30542 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
HPGD P15428 1/20 0.37
CYP2D6 P10635 6/20 0.36
ADRB2 P07550 4/20 0.36
ADRB1 P08588 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14477157 0.78 NR2E1 (0.60) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL19683456 0.76 KDM4E (0.55) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL19683357 0.74 NR2E1 (0.44) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL6298086 0.74 NR2E1 (0.46) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL17726898 0.69 CTSL (0.50) MEN1KMT2AADORA3NPC1MAPT
SCHEMBL3767592 0.68 TLR8 (0.50) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL17733184 0.66 ADORA3 (0.48) CYP1A2MEN1CYP2C19KMT2AADORA3
SCHEMBL6663577 0.66 ALOX15 (0.53) CYP1A2KDM4ECYP2C19MAPTALDH1A1
SCHEMBL27983585 0.65 NQO1 (0.39) NR2E1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL7046801 0.65 KDM1A (0.48) MEN1KMT2ASMN1; SMN2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304595-A1 Electroactive Compounds LG CHEM, LTD. (KR) 2025-10-02 US disclosed
WO-2017210072-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304595-A1 Electroactive Compounds NAT1, NES, SULT1E1 NR2E1 13/4885CYP1A2 901/4885KDM4E 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.